Exact Sciences Corporation (EXAS) was one of the Russell 2000's biggest losers for Thursday February 18 as the stock slid 7.26% to $6.13, a loss of $-0.4799 per share. Starting at an opening price of $6.59 a share, the stock traded between $6.11 and $6.69 over the course of the trading day. Volume was 795,116 shares over 6,677 trades, against an average daily volume of 3 million shares and a total float of 96.34 million.
The losses send Exact Sciences Corporation down to a market cap of $590.56 million. In the last year, Exact Sciences Corporation has traded between $32.85 and $5.37, and its 50-day SMA is currently $7.52 and 200-day SMA is $16.82.
Exact Sciences Corp is a molecular diagnostics company currently focused on the early detection and prevention of colorectal cancer. It has developed a non?invasive, patient friendly screening test called Cologuard(R).
Exact Sciences Corporation is based out of Madison, WI and has some 236 employees. Its CEO is .
For a complete fundamental analysis analysis of Exact Sciences Corporation, check out Equities.com’s Stock Valuation Analysis report for EXAS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.